📗 Cite This Artifact
EGR4
EGR4
<div class="infobox infobox-gene">
<div class="infobox-header">EGR4</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Early Growth Response 4</div>
<div class="infobox-row"><strong>Symbol:</strong> EGR4</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2p13.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 1961</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000186866</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q05266</div>
<div class="infobox-row"><strong>Protein Length:</strong> 476 amino acids</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~54 kDa</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Cognitive Impairment</div>
</div>
</div>
Overview
...
EGR4
<div class="infobox infobox-gene">
<div class="infobox-header">EGR4</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Early Growth Response 4</div>
<div class="infobox-row"><strong>Symbol:</strong> EGR4</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 2p13.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 1961</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000186866</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q05266</div>
<div class="infobox-row"><strong>Protein Length:</strong> 476 amino acids</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~54 kDa</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Cognitive Impairment</div>
</div>
</div>
Overview
EGR4 (Early Growth Response 4) is a zinc finger transcription factor and member of the EGR (Early Growth Response) family of immediate-early genes. The gene is located on chromosome 2p13.3 and encodes a 476-amino acid protein containing three C2H2-type zinc finger motifs in its DNA-binding domain. EGR proteins recognize the DNA sequence 5'-GCG(T/G)GGGCG-3' (EGR consensus) and regulate target gene expression in response to various cellular stimuli including neuronal activity, growth factors, and stress. Unlike other EGR family members (EGR1-3), EGR4 has a relatively restricted expression pattern with highest levels in the brain (particularly [hippocampus](/brain-regions/hippocampus) and cortex) and testis. EGR4 is classified as an activity-dependent transcription factor that regulates late-phase [long-term potentiation](/mechanisms/long-term-potentiation) (L-LTP) and is involved in synaptic plasticity, neurotransmitter release, and neuronal gene expression programs. Research suggests EGR4 may play roles in neurodegenerative diseases through dysregulation of activity-dependent transcriptional responses, altered neuronal injury responses, and potential involvement in synaptic dysfunction observed in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [1][2].
Function
Transcriptional Regulation
EGR4 functions as a sequence-specific DNA-binding transcription factor with the following characteristics:
DNA-Binding Domain: The C2H2 zinc finger domain consists of three zinc fingers that coordinate zinc ions and fold into a structure capable of sequence-specific DNA binding:
Transcriptional Activation: EGR4 contains transcriptional activation domains at its N-terminus that recruit co-activators including:
- CREB-binding protein (CBP)
- Histone acetyltransferases
- Mediator complex components
- Synaptic plasticity
- Neuronal excitability
- Neuroprotection
- Axon guidance
- Cytoskeletal dynamics
Activity-Dependent Transcription
EGR4 is classified as an immediate-early gene (IEG) that is rapidly induced by neuronal activity:
Induction Pathways:
De novo transcription: Unlike some IEGs that may be pre-formed and released, EGR4 requires new transcription, making it a true IEG whose expression signals ongoing neuronal activity.
Long-Term Potentiation
EGR4 plays a critical role in late-phase LTP:
L-LTP Maintenance: Sustained transcriptional activation through EGR4 and other IEGs is required for the consolidation of LTP. EGR4 expression persists hours after LTP induction.
Synaptic Tagging: EGR4 may contribute to the "synaptic tagging" mechanism that allocates proteins to potentiated synapses.
Synaptic Protein Synthesis: EGR4 regulates expression of synaptic proteins including:
- Synaptic vesicle proteins
- Postsynaptic density proteins
- Ion channel subunits
Expression
Tissue Distribution
EGR4 exhibits restricted tissue distribution compared to other EGR family members:
| Tissue | Expression Level |
|--------|-----------------|
| Brain (hippocampus CA1-CA3) | Very High |
| Brain (cerebral cortex, layer V) | Very High |
| Brain (olfactory bulb) | High |
| Brain (hypothalamus) | Moderate-High |
| Brain (cerebellum) | Low-Moderate |
| Testis | High |
| Adrenal gland | Moderate |
| Pituitary | Moderate |
Cellular Localization
In neurons, EGR4 localizes to:
- Nucleus: Primary location for transcriptional function
- Dendrites: Activity-dependent translocation to dendritic compartments
- Synaptic terminals: May have additional roles in presynaptic plasticity
Disease Associations
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), EGR4 dysregulation contributes to:
Synaptic Dysfunction: LTP deficits in AD models correlate with altered EGR4 expression. Normal EGR4 function is required for activity-dependent synaptic strengthening, which is impaired in amyloid-rich environments [3].
Transcriptional Dysregulation: AD is associated with widespread transcriptional alterations. EGR4 changes may contribute to the "activity-dependent transcription deficit" observed in AD neurons.
Memory Impairment: Since EGR4 is required for memory consolidation, its dysfunction may contribute to early memory deficits in AD.
Neuroprotection: EGR4 regulates genes involved in neuronal survival. Loss of EGR4 function may render neurons more vulnerable to toxic insults.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
Dopaminergic Signaling: EGR4 is highly expressed in striatal medium spiny neurons where it responds to dopaminergic signaling. This may be relevant to PD pathophysiology.
Neuroprotection: EGR4 may regulate neuroprotective genes whose expression is reduced in PD.
Alpha-Synuclein Response: EGR4 expression changes in response to alpha-synuclein pathology, though the functional significance is unclear.
Cognitive Impairment
EGR4 deficiency has been linked to:
- Learning deficits in mouse models
- Impaired memory consolidation
- Reduced LTP maintenance
Mechanism of Action
Signal Transduction Cascades
EGR4 induction involves multiple signaling pathways:
Target Genes
EGR4 regulates numerous downstream genes:
| Gene Category | Examples | Function |
|---------------|-----------|----------|
| Synaptic proteins | Synapsin, PSD95 | Synaptic plasticity |
| Ion channels | Cav1.2, Kv4.2 | Neuronal excitability |
| Transcription factors | c-Fos, Arc | Gene cascades |
| Neurotrophins | BDNF, NGF | Neuronal survival |
| Cytoskeletal | MAP2, Tau | Neurite outgrowth |
Chromatin Remodeling
EGR4 influences chromatin state through:
- Recruitment of histone acetyltransferases (CBP/p300)
- Interaction with chromatin remodelers
- Promoter and enhancer accessibility
Interaction Network
| Partner | Interaction Type | Functional Role |
|---------|-----------------|-----------------|
| DNA (EGR consensus) | Direct binding | Sequence-specific binding |
| CBP/p300 | Co-activator | Histone acetylation |
| CREB | Partner TF | Co-regulation |
| Elk-1 | Partner TF | Serum response element |
| NGF | Inducer | Transcriptional activation |
| BDNF | Inducer | Activity-dependent regulation |
Therapeutic Implications
Modulating EGR4 Activity
EGR4 in Drug Discovery
- Screen for EGR4 inducers: Compounds that enhance EGR4 expression
- Epigenetic modulators: HDAC inhibitors may enhance EGR4 expression
- Cell-penetrant peptides: Designed to modulate EGR4 function
Research Models
- EGR4 knockout mice: Show learning and memory deficits
- Conditional knockouts: Brain-region specific deletion
- iPSC models: Neurons derived from AD/PD patients
- In vitro systems: Primary neuron cultures
Key Publications
See Also
- [EGR Family](/proteins/egr-protein-family)
- [Transcription factors](/mechanisms/transcription-factor-dysfunction)
- [Synaptic plasticity](/mechanisms/synaptic-plasticity)
- [Long-term potentiation](/mechanisms/long-term-potentiation)
- [Immediate-early genes](/mechanisms/immediate-early-genes)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: EGR4](https://www.ncbi.nlm.nih.gov/gene/1961)
- [UniProt: Q05266](https://www.uniprot.org/uniprot/Q05266)
- [Ensembl: ENSG00000186866](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000186866)
- [PubMed: EGR4 neuroscience](https://pubmed.ncbi.nlm.nih.gov/?term=EGR4+synaptic+plasticity)
References
Pathway Diagram
The following diagram shows the key molecular relationships involving EGR4 discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-egr4 |
| kg_node_id | EGR4 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-e14a4797bed3 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-egr4'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-egr4?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[EGR4](http://scidex.ai/artifact/wiki-genes-egr4)
http://scidex.ai/artifact/wiki-genes-egr4